CONFERENCE COVERAGE
American Society for Bone and Mineral Research
Annual Meeting
2020 COVERAGE
- Short-Term Romosozumab Use Highly Effective in RA and Primary Osteoporosis
- Vitamin D Deficiency Associated With Increased Inflammatory Activity in SpA
- Serious Infection Risk Not Significantly Higher With Denosumab vs Alendronate in Osteoporosis
- Increased Osteoporotic Fracture Risk Among Patients With RA Receiving Oral Glucocorticoids and PPIs
- T2D Has Detrimental Effects on Trabecular Bone Quality in Osteoporosis
- Self-Reported Frailty Prevalent Among Patients With RMDs
Latest Tweets
Follow
@RheumAdvisor
Conference Coverage from
